UK Biotech Thalia Therapeutics Secures €3.1 Million to Acquire US-Based Sanmirna and Expand RNA Pipeline

Thalia Therapeutics, a UK-based biotech company, raised €3.1 million and acquired Sanmirna Therapeutics, a US-based clinical-stage biotech, to advance its RNA therapeutics pipeline in oncology and cardiovascular disease. The acquisition includes miRisten, a clinical-stage microRNA therapeutic for Acute Myeloid Leukaemia (AML).

German and Ukrainian robotics firms establish joint venture to scale UGV production for Ukrainian military

ARX Industries, a joint venture between ARX Robotics (Germany) and Roboneers (Ukraine), aims to scale production of Rys Pro UGVs for the Ukrainian military. The partnership combines industrial capacity with frontline deployment expertise to meet Ukraine’s 2026 target of 50,000 UGVs.

Irish HR Platform HR Duo Secures €1.6 Million to Accelerate UK Expansion

HR Duo, an Irish HR platform for SMEs with frontline workforces, raised €1.6 million led by Puma Growth Partners and Enterprise Ireland to expand in the UK and scale its SaaS infrastructure. The funding supports targeting a €500-700 million SME HRTech market, with plans to achieve 41% ARR growth in 2026.